Manufacturers Life Insurance Company, The Magenta Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$6.07 - $9.89 $119,852 - $195,278	-19,745 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$9.76 - $14.15 $53,738 - $77,909	5,506 Added 38.67%	19,745 $193,000
Q1 2021 May 03, 2021	SELL	$7.66 - $13.38 $5,967 - $10,423	-779 Reduced 5.19%	14,239 $169,000
Q4 2020 Feb 12, 2021	BUY	$6.1 - $7.94 $15,213 - $19,802	2,494 Added 19.91%	15,018 $118,000
Q3 2020 Nov 09, 2020	BUY	$6.52 - $8.94 $5,496 - $7,536	843 Added 7.22%	12,524 $85,000
Q2 2020 Aug 10, 2020	SELL	$6.18 - $10.76 $11,575 - $20,153	-1,873 Reduced 13.82%	11,681 $87,000
Q1 2020 May 15, 2020	BUY	$6.03 - $15.24 $2,761 - $6,979	458 Added 3.5%	13,554 $85,000
Q4 2019 Feb 14, 2020	SELL	$9.07 - $15.84 $3,256 - $5,686	-359 Reduced 2.67%	13,096 $199,000
Q3 2019 Nov 12, 2019	BUY	$9.63 - $14.0 $1,059 - $1,540	110 Added 0.82%	13,455 $130,000
Q2 2019 Aug 14, 2019	BUY	$13.4 - $17.67 $178,823 - $235,806	13,345 New	13,345 $197,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.